Nirvana Life Sciences Inc.
NIRV
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -44.70K | -40.90K | -256.30K | 4.00K | -124.00K |
| Total Depreciation and Amortization | -- | -- | 4.50K | 9.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.30K | -100.00 | 135.70K | -109.00K | 33.80K |
| Change in Net Operating Assets | 3.40K | 40.20K | 111.80K | 89.70K | 38.30K |
| Cash from Operations | -21.00K | -800.00 | -4.30K | -6.30K | -51.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 37.60K | 5.30K | 4.60K | 2.00K | 13.60K |
| Total Debt Repaid | -- | -- | 50.00K | 0.00 | 0.00 |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 25.00K |
| Repurchase of Common Stock | -- | -- | -59.10K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 9.10K | 0.00 | 0.00 |
| Cash from Financing | 27.60K | 3.80K | 3.40K | 1.50K | 28.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -9.10K | -2.20K | -- | -- | -- |
| Net Change in Cash | -2.50K | 800.00 | -900.00 | -4.80K | -23.40K |
